These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 187885)

  • 1. Effect of naloxone on antinociceptive activity of phenoxybenzamine.
    Elliott HW; Spiehler V; Navarro G
    Life Sci; 1976 Dec; 19(11):1637-43. PubMed ID: 187885
    [No Abstract]   [Full Text] [Related]  

  • 2. Antinociceptive actions of clonidine.
    Fielding S; Spaulding TC; Lal H
    Prog Clin Biol Res; 1981; 71():225-42. PubMed ID: 6276895
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of phentolamine, tolazoline and phenoxybenzamine on the response of the isolated spleen strip to electrical stimulation and noradrenaline.
    Greenberg R
    Arch Int Pharmacodyn Ther; 1970 Apr; 184(2):227-32. PubMed ID: 5460188
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of phenoxybenzamine on the narcotic withdrawal syndrome in the rat.
    Cicero TJ; Meyer ER; Bell RD
    Neuropharmacology; 1974 Jul; 13(7):601-7. PubMed ID: 4155053
    [No Abstract]   [Full Text] [Related]  

  • 5. Differential effects on morphine analgesia and naloxone antagonism by biogenic amine modifiers.
    Takemori AE; Tulunay FC; Yano I
    Life Sci; 1975 Jul; 17(1):21-7. PubMed ID: 1143009
    [No Abstract]   [Full Text] [Related]  

  • 6. Memory facilitation by naloxone is due to release of dopaminergic and beta-adrenergic systems from tonic inhibition.
    Izquierdo I; Graudenz M
    Psychopharmacology (Berl); 1980; 67(3):265-8. PubMed ID: 6247739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The local monoaminergic dependency of spinal ketamine.
    Crisp T; Perrotti JM; Smith DL; Stafinsky JL; Smith DJ
    Eur J Pharmacol; 1991 Mar; 194(2-3):167-72. PubMed ID: 1647967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term enhancement of morphine hypalgesia as a result of periodic blockade of opiate receptors using naloxone].
    Kiiatkin EA; Zhukov VN
    Biull Eksp Biol Med; 1987 Dec; 104(12):692-5. PubMed ID: 2825840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biphalin preferentially recruits peripheral opioid receptors to facilitate analgesia in a mouse model of cancer pain - A comparison with morphine.
    Lesniak A; Bochynska-Czyz M; Sacharczuk M; Benhye S; Misicka A; Bujalska-Zadrozny M; Lipkowski AW
    Eur J Pharm Sci; 2016 Jun; 89():39-49. PubMed ID: 27094782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antinociceptive effects of stimulation of discrete sites in the rat hypothalamus: evidence for the participation of the lateral hypothalamus area in descending pain suppression mechanisms.
    Franco AC; Prado WA
    Braz J Med Biol Res; 1996 Nov; 29(11):1531-41. PubMed ID: 9196558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation by TRH of the effect of imipramine on the forced-swimming test.
    Reny-Palasse V; Rips R
    Br J Pharmacol; 1985 Jun; 85(2):463-70. PubMed ID: 2992664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism by phenoxybenzamine and pentazocine of the antinociceptive effects of morphine in the spinal cord.
    Russell B; Yaksh TL
    Neuropharmacology; 1981 Jun; 20(6):575-9. PubMed ID: 6894633
    [No Abstract]   [Full Text] [Related]  

  • 13. Antagonist-induced opioid receptor up-regulation. I. Characterization of supersensitivity to selective mu and kappa agonists.
    Millan MJ; Morris BJ; Herz A
    J Pharmacol Exp Ther; 1988 Nov; 247(2):721-8. PubMed ID: 2846827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of some adrenergic blocking agents on gastric secretion in dogs.
    Pradhan SN; Wingate HW
    Arch Int Pharmacodyn Ther; 1966 Aug; 162(2):303-10. PubMed ID: 4381829
    [No Abstract]   [Full Text] [Related]  

  • 15. Chloroxymorphamine, and opioid receptor site-directed alkylating agent having narcotic agonist activity.
    Caruso TP; Takemori AE; Larson DL; Portoghese PS
    Science; 1979 Apr; 204(4390):316-8. PubMed ID: 86208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinal interactions between opioid and noradrenergic agonists in mice: multiplicativity involves delta and alpha-2 receptors.
    Roerig SC; Lei S; Kitto K; Hylden JK; Wilcox GL
    J Pharmacol Exp Ther; 1992 Jul; 262(1):365-74. PubMed ID: 1378095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for sedative effects of low doses of morphine in mice involving receptors insensitive to naloxone.
    Marçais H; Bonnet JJ; Costentin J
    Life Sci; 1981 Jun; 28(24):2737-42. PubMed ID: 6267395
    [No Abstract]   [Full Text] [Related]  

  • 18. Opiate receptors for behavioral analgesia resemble those related to the depression of spinal nociceptive neurons.
    Yaksh TL
    Science; 1978 Mar; 199(4334):1231-3. PubMed ID: 204008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultra-low dose naloxone restores the antinocicepitve effect of morphine in PTX-treated rats: association of IL-10 upregulation in the spinal cord.
    Lin YS; Tsai RY; Shen CH; Chien CC; Tsai WY; Guo SL; Wong CS
    Life Sci; 2012 Sep; 91(5-6):213-20. PubMed ID: 22820166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha adrenergic blocking agents: anti-nociceptive activity and enhancement of morphine-induced analgesia.
    Cicero TJ; Meyer ER; Smithloff BR
    J Pharmacol Exp Ther; 1974 Apr; 189(1):72-82. PubMed ID: 4150877
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.